Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision

Cancers
Kelsey E LewisSamuel C Mok

Abstract

Current ovarian cancer screening guidelines in high-risk women vary according to different organizations. Risk reducing surgery remains the gold standard for definitive treatment in BRCA mutation carriers, but research advancements have created more short-term options for patients to consider. The decisions involved in how a woman manages her BRCA mutation status can cause a great deal of stress and worry due to the imperfect therapy options. The goal of this review was to critically analyze the screening recommendations and alternative options for high-risk ovarian cancer patients and evaluate how these discrepancies and choices affect a woman's management decisions.

References

Jul 1, 1987·Psychosomatic Medicine·B B Sherwin, M M Gelfand
Feb 24, 2001·Controlled Clinical Trials·J K GohaganUNKNOWN Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sunil R LakhaniDouglas F Easton
Jun 16, 2004·CA: a Cancer Journal for Clinicians·Anne S TsaoWaun Ki Hong
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Bethan PowellJohn Ziegler
Oct 20, 2005·The Cochrane Database of Systematic Reviews·W SomboonpornR Bell
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joan L KramerMark H Greene
Oct 3, 2006·The Lancet Oncology·Walter A RoccaL Joseph Melton
Jan 2, 2007·The Lancet Oncology·John R McLaughlinUNKNOWN Hereditary Ovarian Cancer Clinical Study Group
Apr 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sining Chen, Giovanni Parmigiani
Sep 19, 2009·Cancer Treatment and Research·Anna Hoekstra, Gustavo C Rodriguez
Mar 17, 2010·Journal of Minimally Invasive Gynecology·William H Parker
May 25, 2010·Journal of the National Comprehensive Cancer Network : JNCCN·Mary B DalyUNKNOWN National Comprehensive Cancer Network
Jun 15, 2010·Human Reproduction Update·D CibulaL Dusek
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Jul 17, 2010·Human Reproduction Update·D CibulaL Dusek
Aug 10, 2010·Gynecologic Oncology·John O SchorgeThomas J Herzog
Dec 7, 2010·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Jeffrey D SeidmanRobert J Kurman
Jun 7, 2011·JAMA : the Journal of the American Medical Association·Saundra S BuysUNKNOWN PLCO Project Team
Mar 21, 2012·Families, Systems & Health : the Journal of Collaborative Family Healthcare·Lindsey M HoskinsMark H Greene
May 11, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Steven J Skates
Sep 12, 2012·Annals of Internal Medicine·Virginia A Moyer, UNKNOWN U.S. Preventive Services Task Force
Dec 6, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adam N RosenthalIan J Jacobs
Oct 23, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia G MoormanEvan R Myers
Jan 15, 2014·American Journal of Obstetrics and Gynecology·Jessica N McAlpineUNKNOWN Ovarian Cancer Research Program of British Columbia
Feb 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amy P M FinchSteven A Narod
Jun 3, 2014·Molecular Cancer·Mildred FelderManish S Patankar
Sep 10, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E ShermanMark H Greene
Sep 23, 2014·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·David B PortnoyMark H Greene

❮ Previous
Next ❯

Citations

Mar 27, 2019·Cancers·Ainhoa MadariagaAmit M Oza
Feb 26, 2020·Radiology·Elizabeth Suh-BurgmannNatasha Brasic
Mar 8, 2019·Journal of Clinical Medicine·Paola ModaffariNicoletta Biglia
Aug 29, 2020·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·H JiangJ D Wark
Dec 22, 2019·Cryobiology·Romualdo Sciorio, Richard A Anderson

❮ Previous
Next ❯

Methods Mentioned

BETA
hysterectomy

Software Mentioned

ROCA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
B EhlkenJ Tyczynski
Reviews in Obstetrics and Gynecology
Athol Kent
© 2022 Meta ULC. All rights reserved